跳至主要内容
临床试验/NCT02891694
NCT02891694已完成不适用

Metalloproteinases and Recurrent Corneal Erosion Syndrome

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2016年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) in epithelial cells

研究概览

简要总结

Recurrent corneal erosion (RCE) syndrome can be observed either in the context of a dystrophy of the basement membrane or following corneal trauma. This syndrome is characterized by recurrent episodes of ocular pain more or less associated with localized separations between the outer epithelium and the epithelial basal lamina (basement membrane) because of anchorage abnormalities between these two corneal layers. This could be the result of an increased expression of metalloproteinases cleaving the hemidesmosomes which anchor epithelium to the basement membrane.

The investigators hypothesis is that episodes of RCEs are favored by a hyper- expression of matricial metalloprotease 9 (MMP-9) induced by EMMPRIN and Galectin-3. The identification of such induction could lead to development of therapeutics inhibiting EMMPRIN and Galectin- 3 in the RCE syndrome.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Recurrent Corneal Erosion Syndrome, with - failure of medical treatment and therapeutic photokeratectomy scheduled
  • Photorefractive surgical keratectomy (control patients)

排除标准

  • Opposition to participation in the study
  • Known pregnancy or breast-feeding patient
  • No medical insurance coverage

结局指标

主要结局

expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) in epithelial cells

时间窗: baseline

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验